Key result
Phosphorylation or glutamic acid substitution at PKC sites on cardiac troponin I differentially depressed myofilament maximum tension by up to 27% and altered Ca(2+) sensitivity and sliding speed.
Population
Detergent-skinned mouse cardiac fiber bundles and reconstituted thin filament preparations
Comparison
Replacement of endogenous cTnI with cTnI… vs Controls (unmodified/endogenous cTnI)
Design
Preclinical
Authors
Loading...
Site-specific cTnI phosphorylation effects on tension remain preclinical; leaves open targeted myofilament therapies in human disease.
PKC phosphorylation at specific sites on cardiac troponin I differentially modulates myofilament tension and shortening velocity, highlighting the complexity of actin-myosin regulation.
Burkart et al. (2003) studied this question. Phosphorylation or glutamic acid substitution at Protein Kinase C sites on cardiac troponin I vs. Controls was evaluated on Ca(2+)-dependence of force, maximum tension, and sliding speed. Phosphorylation or glutamic acid substitution at PKC sites on cardiac troponin I differentially depressed myofilament maximum tension by up to 27% and altered Ca(2+) sensitivity and sliding speed.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: